Example: Heart Attack
Search clinical trials for: Dose decrease
Total 7779 results
-
NCT04508179Completed
-
NCT03075956Completed
-
NCT03682029Active, not recruitingMyelodysplastic Syndromes | Cytopenia | Chronic Myelomonocytic Leukemia-1
-
NCT04716491Not yet recruiting
-
NCT05348486RecruitingHypoxia | Head and Neck Cancer | Dose Escalation | FMISO
-
NCT01974453Completed
-
NCT06303128Recruiting
-
NCT07476651RecruitingHepatocellular Carcinoma (HCC) | Liver Metastasis | Intrahepatic Cholangiocarcinoma (ICC) | Radioembolization
-
-
NCT04649125Recruiting
-
NCT04137263Completed
-
NCT01364623CompletedFemale Sexual Dysfunction
-
NCT05198271RecruitingRheumatoid Arthritis
-
NCT06723080RecruitingModerate to Severe Atopic Dermatitis
-
NCT06704152RecruitingMDS | ALL, Recurrent, Adult | AML, Adult Recurrent
-
NCT06226545CompletedEye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis
-
NCT00809991Completed
-
-
NCT02783690Completed
-
NCT00447954CompletedNonexudative Age-Related Macular Degeneration, Unspecified Eye, Intermediate Dry Stage
-
NCT05825222Completed
-
NCT03306030Unknown
-
NCT02055989CompletedLocally Advanced Larynx, Hypopharyngeal Squamous Cell Cancers | Locally Advanced Thyroid Cancers
-
NCT05927428Recruiting
-
NCT04026893RecruitingInfertility of Uterine Origin
-
-
NCT03138564CompletedEnd Stage Renal Disease
-
NCT05520242CompletedResponse | Non-response
-
NCT01898962UnknownStage IV or Recurrent Carcinoma or Sarcoma
-
NCT07282145RecruitingEssential Hypertension
-
NCT01684826CompletedVascular Diseases
-
NCT03756103CompletedHypertension,Essential
-
NCT04637919UnknownHand, Foot and Mouth Disease
-
NCT04131595CompletedEquine Encephalitis
-
NCT07462143RecruitingColorectal (Colon or Rectal) Cancer
-
NCT06515925Recruiting
-
NCT06026267RecruitingLiver Cirrhosis | Spontaneous Bacterial Peritonitis
-
NCT05738655RecruitingDiabetes | Metabolic Disease
-
NCT05369078RecruitingT2DM (Type 2 Diabetes Mellitus)